Woodline Partners LP Monte Rosa Therapeutics, Inc. Transaction History

Woodline Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.71 - $9.72 $59,987 - $86,896	8,940 Added 1.78%	511,351 $3.89 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $906,309 - $1.54 Million	126,403 Added 33.62%	502,411 $4.11 Million
Q2 2022 Aug 15, 2022	BUY	$6.15 - $14.99 $2.02 Million - $4.92 Million	327,908 Added 681.72%	376,008 $3.64 Million
Q1 2022 May 16, 2022	BUY	$10.36 - $20.41 $777 - $1,530	75 Added 0.16%	48,100 $674,000
Q4 2021 Feb 14, 2022	SELL	$16.28 - $27.15 $1.4 Million - $2.34 Million	-86,008 Reduced 64.17%	48,025 $981,000
Q3 2021 Nov 15, 2021	SELL	$18.59 - $42.21 $1.38 Million - $3.13 Million	-74,035 Reduced 35.58%	134,033 $2.99 Million
Q2 2021 Aug 16, 2021	BUY	$18.86 - $22.7 $3.92 Million - $4.72 Million	208,068 New	208,068 $4.72 Million

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $426M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.